Literature DB >> 29487092

Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and Definitions.

Surendra Shenoy1, Michael Allon2, Gerald Beathard2, Deborah Brouwer-Maier2, Laura M Dember2, Mark Glickman2, Celeste Lee2, Terry Litchfield2, Charmaine Lok2, Thomas Huber2, Prabir Roy-Chaudhury2, Jack Work2, Melissa West2, Haimanot Wasse1.   

Abstract

Keywords:  Biological Products; Consensus; Humans; Polytetrafluoroethylene; arteriovenous fistula; clinical trial; renal dialysis; vascular

Mesh：

Year:  2018        PMID： 29487092      PMCID： PMC5967685          DOI： 10.2215/CJN.13321216

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  8 in total

1.  III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000.

Authors: 
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

Review 2.  Reporting standards for percutaneous interventions in dialysis access.

Authors:  Richard J Gray; David Sacks; Louis G Martin; Scott O Trerotola
Journal:  J Vasc Interv Radiol       Date:  2003-09       Impact factor: 3.464

Review 3.  FDA Regulatory Perspectives for Studies on Hemodialysis Vascular Access.

Authors:  Frank P Hurst; Robert E Lee; Aliza M Thompson; Brian D Pullin; Douglas M Silverstein
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-24       Impact factor: 8.237

4.  Fostering innovation, advancing patient safety: the kidney health initiative.

Authors:  Patrick Archdeacon; Rachel N Shaffer; Wolfgang C Winkelmayer; Ronald J Falk; Prabir Roy-Chaudhury
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 8.237

Review 5.  Standardized definitions for hemodialysis vascular access.

Authors:  Timmy Lee; Michele Mokrzycki; Louise Moist; Ivan Maya; Miguel Vazquez; Charmaine E Lok
Journal:  Semin Dial       Date:  2011-09-09       Impact factor: 3.455

Review 6.  Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.

Authors:  Gerald A Beathard; Charmaine E Lok; Marc H Glickman; Ahmed A Al-Jaishi; Donna Bednarski; David L Cull; Jeffery H Lawson; Timmy C Lee; Vandana D Niyyar; Donna Syracuse; Scott O Trerotola; Prabir Roy-Chaudhury; Surendra Shenoy; Margo Underwood; Haimanot Wasse; Karen Woo; Theodore H Yuo; Thomas S Huber
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

7.  Overcoming Barriers in Kidney Health-Forging a Platform for Innovation.

Authors:  Peter G Linde; Patrick Archdeacon; Matthew D Breyer; Tod Ibrahim; Jula K Inrig; Reshma Kewalramani; Celeste Castillo Lee; Carolyn Y Neuland; Prabir Roy-Chaudhury; James A Sloand; Rachel Meyer; Kimberly A Smith; Jennifer Snook; Melissa West; Ronald J Falk
Journal:  J Am Soc Nephrol       Date:  2016-04-28       Impact factor: 10.121

Review 8.  The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access.

Authors:  Anton N Sidawy; Lawrence M Spergel; Anatole Besarab; Michael Allon; William C Jennings; Frank T Padberg; M Hassan Murad; Victor M Montori; Ann M O'Hare; Keith D Calligaro; Robyn A Macsata; Alan B Lumsden; Enrico Ascher
Journal:  J Vasc Surg       Date:  2008-11       Impact factor: 4.268
  8 in total
  8 in total

Review 1.  Challenges and novel therapies for vascular access in haemodialysis.

Authors:  Jeffrey H Lawson; Laura E Niklason; Prabir Roy-Chaudhury
Journal:  Nat Rev Nephrol       Date:  2020-08-24       Impact factor: 28.314

2.  A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturation.

Authors:  Christoph B Olivier; Vandana Sundaram; Glenn M Chertow; Sumana Shashidhar; Lori K McDonnell; Victoria Y Ding; Manisha Desai; Kenneth W Mahaffey; Matthew Mell
Journal:  J Vasc Access       Date:  2019-11-27       Impact factor: 2.283

3.  Efficacy and safety of secondary procedures for maintaining arteriovenous hemodialysis access patency: protocol for a systematic review and network meta-analysis.

Authors:  Mark Rockley; Sudhir Nagpal; Ashish Gupta; Derek J Roberts
Journal:  Syst Rev       Date:  2020-08-21

4.  Vascular access-specific health-related quality of life impacts among hemodialysis patients: qualitative development of the hemodialysis access-related quality of life (HARQ) instrument.

Authors:  Robert J Nordyke; Gina Nicholson; Shawn M Gage; Ted Lithgow; Jonathan Himmelfarb; Matthew B Rivara; Ron D Hays; Karen Woo; John Devin Peipert
Journal:  BMC Nephrol       Date:  2020-01-14       Impact factor: 2.388

5.  Early cannulation of percutaneously created arteriovenous hemodialysis fistulae.

Authors:  Alexandros Mallios; Gerald A Beathard; William C Jennings
Journal:  J Vasc Access       Date:  2019-12-19       Impact factor: 2.283

6.  Radiocephalic Arteriovenous Fistula Patency and Use: A Post Hoc Analysis of Multicenter Randomized Clinical Trials.

Authors:  Patrick Heindel; Peng Yu; Jessica D Feliz; Dirk M Hentschel; Steven K Burke; Mohammed Al-Omran; Deepak L Bhatt; Michael Belkin; C Keith Ozaki; Mohamad A Hussain
Journal:  Ann Surg Open       Date:  2022-08-23

7.  Endovascular Arteriovenous Dialysis Fistula Intervention: Outcomes and Factors Contributing to Fistula Failure.

Authors:  Edwin A Takahashi; William S Harmsen; Sanjay Misra
Journal:  Kidney Med       Date:  2020-04-21

Review 8.  The current and future landscape of dialysis.

Authors:  Jonathan Himmelfarb; Raymond Vanholder; Rajnish Mehrotra; Marcello Tonelli
Journal:  Nat Rev Nephrol       Date:  2020-07-30       Impact factor: 28.314
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.